Clinical Trial Update: A Trial to Evaluate the Efficacy and Safety of Two Concentrations of VBP-926 Solution for the Treatment of Chemotherapy-associated Paronychia in Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating two concentrations of VBP-926 solution for chemotherapy-associated paronychia in cancer patients has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-associated Paronychia

Drugs mentioned

• VBP-926

Snippet

Sponsor: Veloce BioPharma LLC | Conditions: Chemotherapy-Associated Paronychia | Phase 2 | Status: COMPLETED